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In an extended twin study we estimated the heri-tability of fasting HbA1c and blood glucose levels.
Blood glucose was assessed in different settings (at
home and in the clinic). We tested whether the
genetic factors influencing fasting blood glucose
levels overlapped with those influencing HbA1c and
whether the same genetic factors were expressed
across different settings. Fasting blood glucose was
measured at home and during two visits to the clinic
in 77 healthy families with same-sex twins and
 siblings, aged 20 to 45 years. HbA1c was measured
during the first clinic visit. A 4-variate genetic struc-
tural equation model was used that estimated the
heritability of each trait and the genetic correlations
among traits. Heritability explained 75% of the
 variance in HbA1c. The heritability of fasting blood
glucose was estimated at 66% at home and lower in
the clinic (57% and 38%). Fasting blood glucose
levels were significantly correlated across settings
(0.34 < r < 0.54), mostly due to a common set of
genes that explained between 53% and 95% of
these correlations. Correlations between HbA1c and
fasting blood glucoses were low (0.11 < r < 0.23) and
genetic factors influencing HbA1c and fasting glucose
were uncorrelated. These results suggest that in
healthy adults the genes influencing HbA1c and
fasting blood glucose reflect different aspects of the
glucose metabolism. As a consequence these two
glycemic parameters can not be used interchange-
ably in diagnostic procedures or in studies attempting
to find genes for diabetes. Both  contribute unique
(genetic) information.
Keywords: heritability estimates, HbA1c, fasting blood
glucose, twins, type 2 diabetes
Worldwide major efforts are ongoing to identify
genetic variation underlying type 2 diabetes mellitus,
one of the fastest growing threats to health ( Sladek et
al., 2007; Zeggini et al., 2007). To establish the diag-
nosis of type 2 diabetes in the early stage, clinicians
often rely on measurement of fasting blood glucose
(FBG) (A.D.A., 2006) although in some countries
HbA1c levels are used instead (Bennett et al., 2007).
During the course of the disease, type 2 diabetic
patients may control their glucose homeostasis by
measuring their fasting blood glucose, whereas health
professionals mainly use HbA1c to monitor long-term
glycaemia (McCarter et al., 2004; Tapp et al., 2006).
Taken the heritability of type 2 diabetes (Medici et al.,
1999) it is likely that both these indicators are them-
selves heritable.
Heritability of FBG has indeed been well-
 established, but the existing family and twin studies
show large variation in the estimated contribution of
genetic factors. A high heritability (77%) for FBG was
reported in non diabetic first-degree relatives of type 2
diabetic patients (Mills et al., 2004). In contrast a
mere heritability of 21% for the same variable was
found in a large community based study of healthy
families (Freeman et al., 2002). The lowest genetic
influence on the variability of FBG was found by
Schousboe (Schousboe et al., 2003). Heritability in
adult nondiabetic females was only 12%, although
somewhat higher estimates were found for males
(38%). Other twin studies in Western European
 populations showed heritability’s ranging from 38 to
67% (Baird et al., 2001; Katoh et al., 2005; Poulsen et
al., 1999; Snieder et al., 1999; Souren et al., 2007).
A possible explanation for the discrepant heritabil-
ity estimates for FBG is the potential influence of
measurement setting on the relative contribution of
genes and environment to FBG levels. Often the
dietary state of the study participants is well-
 controlled, but blood glucose levels may be sensitive
to many other behavioral factors like recent physical
activity, psychological expectation, and degree of
adaptation to blood letting procedures. These factors
may be determined in part by the setting of blood
letting. Collecting blood during a home visit, for
instance, may lead to quite different behavioural
antecedents than an active visit of the participant to a
597Twin Research and Human Genetics Volume 11  Number 6  pp. 597–602
The Heritability of HbA1c and Fasting Blood
Glucose in Different Measurement Settings
Annemarie M. C. Simonis-Bik,1 Elisabeth M. W. Eekhoff,1 Michaela Diamant,1 Dorret I. Boomsma,2
Rob J. Heine,1 Jacqueline M. Dekker,3 Gonneke Willemsen,2 Marieke van Leeuwen,2 and Eco J. C. de Geus2
1 Diabetes Centre, VU University Medical Centre, 1081 HV Amsterdam, the Netherlands,
2 Biological Psychology, VU University, 1081 BT Amsterdam, the Netherlands
3 EMGO Institute, VU University Medical Centre, 1081 BT Amsterdam, the Netherlands
Received 3 October, 2008; accepted 8 October, 2008.
Address for correspondence: A. M. C. Simonis-Bik, Diabetes Centre,
VU University Medical Centre, ZH 4A62, De Boelelaan 1117, 1081
HV Amsterdam, The Netherlands. E-mail: amc.simonis-bik@vumc.nl
clinic. As part of an extended twin study addressing
the genetic and environmental contribution to the
variance of the beta-cell function in Dutch twin fami-
lies, the first aim of the present study was to estimate
the contribution of genes to the variance of FBG,
obtained in different measurement settings, including
a home visit and two visits to the clinic.
Despite its frequent use as an indicator of long-
term glycaemic control and its established relation to
diabetic complications (Tapp et al., 2006; McCarter et
al., 2004) the genetics of HbA1c has been much less
studied than that of FBG. Only two studies have
reported heritability estimates. Snieder et al. (2001)
found a heritability of 62% in healthy (only female)
twins and an important contribution of age (14%).
The heritability of HbA1c in nondiabetic first-degree
relatives of type 2 diabetic patients was estimated at
55% (Mills et al., 2004). No heritability studies of
HbA1c in male twins are known. A second aim of the
present study was to estimate the heritability of
HbA1c in both sexes.
Based on the idea that FBG and HbA1c are used
interchangeably in the diagnosis and monitoring of
diabetes it is expected that the genes influencing FBG
and HbA1c should be largely overlapping. This has
important consequences for large scale gene finding
efforts that could then pool samples using either one
of these quantitative endophenotypes for diabetes risk.
As a third aim, the present study provides a test of the
expectation that the genes influencing FBG and
HbA1c are largely overlapping.
Materials and Methods
Between September 2004 and December 2006 the
Netherlands Twin Register (Boomsma et al., 2006)
invited 154 twin families by mail to participate in a
study addressing various aspects of beta-cell function,
according to the following inclusion criteria:
Caucasian origin, good general health, aged 20 to 45
years, and having a sibling in the family of the same
sex as the twin pair with a maximum age difference of
5 years. Exclusion criteria were diabetes mellitus,
other relevant metabolic disorders, use of drugs that
affect insulin secretion and/or insulin sensitivity, preg-
nancy and the first 6 months after childbirth. A
minimum of two persons of one family (including one
of the twins) was required. The twin-sibling design
offers the opportunity to distinguish genetic and envi-
ronmental sources of variation based on a comparison
of the resemblance in family members of different
genetic relatedness (Neale & Cardon, 1992). Including
an additional sibling to the classical twin design signif-
icantly increases the power to detect the sources of
variation (Posthuma & Boomsma, 2000).
The study protocol consisted of one home screening
visit to exclude diabetes mellitus by a 75-g oral glucose
tolerance test (OGTT) and one visit to the clinical
research unit; a second visit to the research unit was
optional. The procedures during the respective visits are
outlined below. Fifty per cent of the invited families
agreed to participate. Reasons for nonparticipation
included the lack of time (45%), only one member of
the family wanted to participate (16%), and fear of
needles (13%).
The 77 twin families included consisted of: 51 MZ
pairs (21 male) and 21 DZ pairs (8 male). There were
2 MZ (1male) and 3 DZ (2 male) incomplete twin
pairs. Thirty-one siblings took part in this study (15
male). FBG results of the optional second visit to the
clinic were obtained for 123 subjects (57 male) of 54
families, comprising 33 MZ pairs (14 male), 14 DZ
pairs (7 male) and 7 incomplete twin pairs (3male)
and 22 sibs (12 male). The two groups were compara-
ble in zygosity, sex and BMI, but the group that also
participated in the second visit was 1.5 years younger
(P = 0.043). Twin zygosity was determined from DNA
polymorphisms or, when DNA was not available,
from survey questionnaires (Willemsen et al., 2005).
All subjects gave written informed consent. The
study was approved by the local Ethics Committee
and performed in accordance with the Declaration of
Helsinki (2000).
Measurements
During the screening visit at home an OGTT was per-
formed. At all test occasions participants were
instructed to fast overnight during 12 hours prior to
the visit and to refrain from heavy physical exercise,
alcohol use and smoking. The OGTT was started
between 8.00 and 10.00 am. Fasting and 2-h post-
load capillary blood was obtained and analyzed by a
glucose dehydrogenase method (HemoCue 201+,
Ängelstrom, Sweden) for glucose level (FGBG-O). All
measurements were below diabetic levels (FBG-O <
6.1, 2-h blood glucose < 11.1 mmol/l)
After a median period of 33 days participants
arrived at the clinical research unit at 8:00 a.m. to
undergo a meal test. First, weight (balance scale Seca,
The Netherlands), height (LOG Harpender
Stadiometer, Great Britain) and waist and hip circum-
ference were measured. Second, subjects assumed a
semi-recumbent position with their non-dominant
hand resting in a heating box (50 ºC) to obtain arteri-
alized blood from a dorsal hand vein for measurement
of among others fasting blood glucose and HbA1c.
Whereas the test-tube for HbA1c determination was
immediately transported to the clinical chemistry
department (see below), fasting blood glucose was
assessed at bedside using a glucose oxidase method
(YSI 2300 Stat plus, Yellow Springs, OH, USA). At an
interval of 5 minutes, a second blood sample was
taken for baseline fasting glucose (FBG-M) and hor-
monal levels. After the initial blood sampling the
meal-test was started.
Sixty-nine per cent of the participants returned to
the clinic after a median period of 43 days at 8:00
a.m. for an optional (combined eu-and hypergly-
caemic) clamp test. As before, two arterialized blood
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samples were drawn from the dorsal hand vein for
measurement of fasting glucose (FBG-C) and hor-
monal levels at a 5-minute interval. After this, the
clamp test was started.
Laboratory Analysis
Analyses of HbA1c were performed at the VU
University Medical Centre (department of Clinical
Chemistry), Amsterdam, the Netherlands, using a
DCCT standardized reversed-phase cation exchange
chromatography (HA 8160 analyzer, Menarini,
Florence, Italy). The HbA1c is detected by a dual-
wavelength colorimetric (415-500). The intra-assay
coefficient of variation (CV) is 0.6% at a mean of
4.9% and the inter-assay CV is 0.8 % at a mean of
5.5%. The HemoCue method has a CV of 1.5–2.5 %
and correlates strongly with the YSI (r = .978; Stork et
al., 2005). The YSI has a within run CV of 2 % and a
day-to-day CV of 6% (Astles et al., 1996). The two
repeated measurements of FBG at each of the clinic
visits showed strong test-retest correlations across the
5-minute intervals (.90 < r < .93) and the mean value
across the two measurements was used in all FBG
analyses.
Data Analyses
Structural equation modelling was carried out in Mx
(Neale et al., 2006). In a first step, a 4-variate uncon-
straint model was used to estimate means, variances
and regression coefficients for covariates sex and age
for each phenotype (HbA1c, FBG-O, FBG-M, FBG-C).
Estimates of within trait and cross-traits correlations
for MZ, DZ and twin-sib pairs were also obtained from
this model. In the 4-variate analysis the following tests
were carried out: (1) test of equality of means and vari-
ances for MZ and DZ twins and siblings, (2) equality
of covariances for DZ twins and siblings, and (3) test of
significance of age and sex regressions on the means.
Likelihood-ratio tests were employed to identify the
best model for the 4-variate data.
MZ and DZ twin and twin-sib correlations, within
person correlations between traits and cross-twin
cross-trait correlations (e.g., between HbA1c level of
the oldest twin and FBG-O level of the youngest twin)
were estimated in the most parsimonious model. Next,
a genetic triangular decomposition was fitted to the
data (Fig. 1). An ACE model consisting of Additive
genetic, Common environmental and unique
Environmental factors were used. The raw data option
in Mx was used and the influence of covariates sex
and age was incorporated as fixed effects on the mean.
Results
FBG and HbA1c results on the OGTT and mixed
meal test were obtained for 180 subjects (76 male)
from 77 twin families, from which 51 MZ pairs and
60 DZ/sibling pairs (21 DZ) could be formed. FBG
results on the optional clamp test were obtained for
123 subjects (57 male) from 54 twin families, from
which 33 MZ pairs and 40 DZ/sibling pairs (14 DZ)
could be formed.
Table 1 lists the mean values of the glycaemic para-
meters separately for men and women. There was a
significant sex effect on FBG in the hospital settings (p <
.001), with men having higher values than women. Age
had a significant positive influence on HbA1c (β  =
0.015 ; p .003) and FBG-C (β  = 0.014 ; p .032)
The phenotypic correlations between the FBG
levels in different settings were significant, albeit to a
modest extent: r = 0.49 (CI = 0.35–0.61) between
FBG-O and FBG-M, r = .34 (CI = 0.16–0.49) between
FBG-O and FBG-C and r = .54 (CI = 0.39–0.67)
between FBG levels in the two clinical settings. In con-
trast, the correlations for HbA1c with FBG-O (r = .11,
CI = –0.06–0.23 ), FBG-M (r = .15, CI = –0.02–0.31)
and FBG-C (r = .23, CI = 0.05–0.41 ) were low and
achieved significance only for FBG-C.
Table 2 shows the MZ and DZ/Sibling correlations
with the 95% confidence intervals on the diagonal.
MZ twin pairs resembled each other more strongly
than the same-sex DZ twin and sibling pairs for all
indicators of glycaemia, except for the FBG-C. The
lower part of Table 2 gives the cross-trait cross-twin
correlations. For the various FBG measurements these
cross-trait correlations were generally higher in MZ
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Figure 1
Genetic model for HbA1c and three FBG measures, with factor loadings
of observed variables on the latent additive genetic and unique 
environmental factors.
Note: FBG-O = fasting blood glucose at home; FBG-M = fasting blood glucose pre-
meal; FBG-C = fasting blood glucose pre-clamp. Bold line = significant; dotted
line = nonsignificant.
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Table 1
Maximum Likelihood Estimates of Means and Standard Deviations (SD)
Variable Mean Mean SD
male female
Age (years) 30.32 30.84 4.63
HbA1c (%) 5.29 5.20 0.25
FBG-O (mmol/l) 4.71 4.56 0.45
FBG-M (mmol/l) 4.53 4.27 0.37
FBG-C (mmol/l) 4.61 4.29 0.31
Note: FBG-O, fasting blood glucose at home; FBG-M, fasting blood glucose before
meal; FBG-C, fasting blood glucose before clamp
pairs than in DZ pairs, suggesting that genetic factors
contribute to the correlation between FBG in the three
different settings. No shared genetic contribution is
evident for HbA1c and FBG in any setting.
Table 3 shows the model fitting results, starting
with the full ACE model and ending in the most parsi-
monious AE model. Figure 1 illustrates this final
model and presents the factor loadings of the observed
variables on the different latent factors. This model
resulted in heritability estimates of 66% (CI = 50–
77%) for FBG obtained during the test at home, 57%
(CI = 40–71%) for FBG determined before the meal
test, and 38% (CI = 11–58%) for FBG measured
during the pre-clamp baseline condition. Heritability
of HbA1c was 75% (CI = 62–84%). The model
showed that correlation of FBG across the three differ-
ent settings was due to shared genetic as well as
unique environmental influences (bold arrows).
However, the contribution of the genetic factors was
most striking, accounting for 78% of the covariance
between FBG-O and FBG-M, 95% for FBG-O and
FBG-C and 53% for FBG-M and FBG-C respectively.
In keeping with the low phenotypic correlations, no
significant genetic or environmental correlations were
found between HbA1c and the FBG in any of the
three settings.
Discussion
The present study shows substantial contribution of
genetic influences to the variance in fasting blood
glucose levels although heritability estimates varied
across different measurement settings. The highest her-
itability estimate (66%) was found in the most natural
environment, when FBG was assessed at home.
Comparable heritability (57%) was found in the clinic
during the pre-meal test. The lowest heritability (38%)
was found on the final and most demanding test day,
obtained pre-clamp when subjects knew they had to
undergo invasive tests during the whole day. These dif-
ferent heritability estimates across settings may
account for part of the discrepancy in heritability esti-
mates found in the literature.
Inspection of the estimates of the variance compo-
nents showed that the lower heritability of FBG on the
pre-clamp assessment was mainly caused by differ-
ences in genetic variances in the three settings,
whereas estimates of environmental variances were
largely similar. We cannot rule out, however, that these
‘setting’ differences simply reflect the substantial day-
to-day variation reported for FBG (Balion et al.,
2007). Such day-to-day variation is also evident in the
modest phenotypic correlations between the repeated
measurements of FBG across the three different set-
tings (.34 < r < .54). Importantly, the stable part of the
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Table 2
MZ and DZ / Sibling Correlations and Cross-Trait Correlations (95% Confidence Interval)
HbA1c FBG-O FBG-M FBG-C
MZ
HbA1c 0.75 (0.61 to 0.84) 
FBG-O 0.14 (–0.05 to 0.32) 0.63 (0.42 to 0.76) 
FBG-M 0.12 (–0.06 to 0.30) 0.36 (0.19 to 0.51) 0.56 (0.37 to 0.70) 
FBG-C 0.16 (–0.04 to 0.35) 0.27 (0.06 to 0.46) 0.24 (0.02 to 0.44) 0.35 (0.05 to 0.58)
DZ /sibling
HbA1c 0.47 (0.22 to 0.65) 
FBG-O 0.08 (–0.12 to 0.65) 0.53 (0.31 to 0.69) 
FBG-M 0.07 (–0.13 to 0.26) 0.31 (0.12 to 0.47) 0.37 (0.12 to0.56) 
FBG-C 0.18 (–0.03 to 0.37) 0.26 (0.05 to 0.45) 0.32 (0.10 to0.56) 0.39 (0.11 to 0.60)
Note: FBG-O, fasting blood glucose at home; FBG-M, fasting blood glucose before meal; FBG-C, fasting blood glucose before clamp. Twin correlations on the  diagonal; cross-trait
cross-twin correlations off-diagonal.
Table 3
Model Fitting Results For Multivariate Analyses of FBG in Different Settings and HbA1c
Test Model –2LL df vs. Δdf ΔΧ² P
1 ACE 4.325.946 623
2 CE 4.340.964 633 1 10 15.018 0.131
3 AE 4.333.074 633 1 10 7.128 0.713
4 E 4.455.775 643 1 20 129.829 <0.001
5 AE, no nonsignificant parameters 4.340.422 640 3 7 7.348 0.394
Note: FBG = fasting blood glucose; –2LL= –2 log likelihood; df = degrees of freedom; vs.= compared to model; A = additive genetic influences; C = shared environmental; E = non-
shared environment. Δ = difference; Significant age and sex covariates are included in all models. Preferred model in bold.
individual differences in FBG across settings could be
largely attributed to common genetic factors that influ-
ence FBG irrespective of the setting of the blood
collection. Large collaborative gene finding efforts that
pool FBG samples across many different studies and
countries have tacitly assumed that the exact setting in
which FBG was obtained (clinic vs. home; OGTT ,
meal or clamp studies) should not matter. The data
from the present study confirm that such gene-finding
efforts may safely pool samples from different settings.
Heritability of HbA1c was estimated at 75%,
which is higher than reported by two previous studies
(Mills et al., 2004; Snieder et al., 2001). Because FBG
and HbA1c are used interchangeably in the diagnosis
and monitoring of diabetes it was expected that the
genes influencing FBG and HbA1c should be largely
overlapping. This expectation was not confirmed.
Phenotypic correlations between HbA1c and FBG
were either small or non-significant and no evidence
was found for common genetic factors influencing
FBG and HbA1c.
The small correlation among FBG and HbA1c and
the lack of common genetic influences are in line with
the study of Monnier (2003) that showed only modest
contribution of fasting glucose levels to the variance of
HbA1C. On the contrary, the correlation between
mean blood glucose (measured by continuous glucose
monitoring over the preceeding 12 weeks) and
HbA1C is much higher reaching up to a correlation of
0.9 (Nathan et al., 2007). This suggests that non-
fasting glucose levels are important determinants of
HbA1C, allowing genetic factors influencing dietary
habits, and behavioral and physical activity patterns
to enter into the heritability of Hb1AC In addition,
non-glucose related factors may contribute to the heri-
tability of HbA1c as there are substantial individual
differences in glycation rate and intra-erytrocyt metab-
olism(Cohen et al., 2006; Gould et al., 1997; Hempe
et al., 2002). Importantly, a recent Japanese study
(Inoue et al., 2007) suggests that both HbA1C and
FBG contribute information on diabetes risk. HbA1c
and fasting plasma glucose independently predicted
the progression to diabetes in a healthy population,
particularly when the FBG was ≥ 5.55 mmol/l.
In summary, the results of the present study
suggest that in healthy adults the genes influencing
FBG in different settings are largely overlapping.
HbA1c and FBG, however, reflect different aspects of
the genetics of glucose metabolism. As a consequence,
these two glycemic parameters cannot be used inter-
changeably in diagnostic procedures or in studies
attempting to find genes for diabetes. Both contribute
unique (genetic) information.
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